150 related articles for article (PubMed ID: 8863670)
1. Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors.
Scotlandi K; Baldini N; Oliviero M; Di Renzo MF; Martano M; Serra M; Manara MC; Comoglio PM; Ferracini R
Am J Pathol; 1996 Oct; 149(4):1209-19. PubMed ID: 8863670
[TBL] [Abstract][Full Text] [Related]
2. The expression of Met/hepatocyte growth factor receptor gene in giant cell tumors of bone and other benign musculoskeletal tumors.
Ferracini R; Scotlandi K; Cagliero E; Acquarone F; Olivero M; Wunder J; Baldini N
J Cell Physiol; 2000 Aug; 184(2):191-6. PubMed ID: 10867643
[TBL] [Abstract][Full Text] [Related]
3. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.
Ferracini R; Di Renzo MF; Scotlandi K; Baldini N; Olivero M; Lollini P; Cremona O; Campanacci M; Comoglio PM
Oncogene; 1995 Feb; 10(4):739-49. PubMed ID: 7862451
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
5. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.
Wallenius V; Hisaoka M; Helou K; Levan G; Mandahl N; Meis-Kindblom JM; Kindblom LG; Jansson JO
Am J Pathol; 2000 Mar; 156(3):821-9. PubMed ID: 10702398
[TBL] [Abstract][Full Text] [Related]
7. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
Hepatology; 1997 Apr; 25(4):862-6. PubMed ID: 9096589
[TBL] [Abstract][Full Text] [Related]
8. [Expression of hepatocyte growth factor and its receptor, C-Met in human digestive tissues and different gastric and colonic cancer cell lines].
Kermorgant S; Cadiot G; Lewin MJ; Lehy T
Gastroenterol Clin Biol; 1996; 20(5):438-45. PubMed ID: 8761141
[TBL] [Abstract][Full Text] [Related]
9. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma.
Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
Hepatology; 1997 Mar; 25(3):619-23. PubMed ID: 9049208
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.
Di Renzo MF; Olivero M; Ferro S; Prat M; Bongarzone I; Pilotti S; Belfiore A; Costantino A; Vigneri R; Pierotti MA
Oncogene; 1992 Dec; 7(12):2549-53. PubMed ID: 1334253
[TBL] [Abstract][Full Text] [Related]
11. Expression of the Met/HGF receptor in normal and neoplastic human tissues.
Di Renzo MF; Narsimhan RP; Olivero M; Bretti S; Giordano S; Medico E; Gaglia P; Zara P; Comoglio PM
Oncogene; 1991 Nov; 6(11):1997-2003. PubMed ID: 1719465
[TBL] [Abstract][Full Text] [Related]
12. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
13. Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript.
Moghul A; Lin L; Beedle A; Kanbour-Shakir A; DeFrances MC; Liu Y; Zarnegar R
Oncogene; 1994 Jul; 9(7):2045-52. PubMed ID: 8208549
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
Tuck AB; Park M; Sterns EE; Boag A; Elliott BE
Am J Pathol; 1996 Jan; 148(1):225-32. PubMed ID: 8546209
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis.
Furukawa T; Duguid WP; Kobari M; Matsuno S; Tsao MS
Am J Pathol; 1995 Oct; 147(4):889-95. PubMed ID: 7573364
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas.
Harvey P; Warn A; Newman P; Perry LJ; Ball RY; Warn RM
J Pathol; 1996 Dec; 180(4):389-94. PubMed ID: 9014859
[TBL] [Abstract][Full Text] [Related]
17. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of hepatocyte growth factor on human cord blood CD34+ progenitor cells are the result of c-met receptor expression.
Goff JP; Shields DS; Petersen BE; Zajac VF; Michalopoulos GK; Greenberger JS
Stem Cells; 1996 Sep; 14(5):592-602. PubMed ID: 8888500
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue.
Nakashiro K; Hayashi Y; Oyasu R
Oncol Rep; 2003; 10(5):1149-53. PubMed ID: 12883672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]